Analyst Julien Ouaddour of Bank of America Securities maintained a Buy rating on Alcon, retaining the price target of CHF80.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Julien Ouaddour has given his Buy rating due to a combination of factors that indicate positive momentum for Alcon. The company reported a slight improvement in its third-quarter results for fiscal year 2025, surpassing expectations with a 3% earnings per share beat and a 5% constant currency sales growth. This performance has alleviated investor concerns that arose from previous quarters of underperformance and guidance adjustments.
Alcon’s ability to meet or exceed expectations in most divisions, except for Contact Lenses, has contributed to a more optimistic outlook. The launch of PanOptix Pro has helped the company regain growth in the Implantables segment, while Consumables and Equipment have shown robust performance. The reiterated guidance for fiscal year 2025, with realistic sales growth and margin targets, alongside the positive trends in Ocular Health, further support the confidence in Alcon’s future performance, justifying the Buy rating.
In another report released yesterday, Needham also reiterated a Buy rating on the stock with a $101.00 price target.